Gain Therapeutics Company
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
%20.jpg)
Funding Status:
IPO
Industry:
Preclinical Development
Estimated Revenue:
Less than $1M
Headquarters:
Bethesda, Maryland, United States
Total Funding:
14396508.0
Last Funding Date:
2020-07-21
Last Funding Type:
Series B
Investors Number:
6.0
Founded Date:
2017-01-01